Phil. Thanks,
begin Let's X. on Slide
driven quarter delivered we of several QX quarter, factors. of our million record discussed XX% in prior the results, in pleased impressive very a are year We the We continuation versus which up $XXX by the revenues August. with performance first were
strong aided our and our performed consumer building. the business by well majority brand First, portfolio, base time-tested behaviors across of our
strength. wins many The both factors reflects rapid shortly. trends and performance year-to-date. driven share discuss nearly categories organic in all channels our of also growth and was bit in line about across of consumption these a market top detail more occurred the of XX% I'll Our continued by
million Lastly, Akorn's is the a and generated to off $XX.X July acquisition start. revenue solid Consumer in Brands of X
our fully integrated growth confident Clear and the remain have We business outlook into TheraTears' processes fit long-term in Eyes. alongside and
top cash flow, generated $X.XX As versus earnings year. adjusted free adjusted both cash digits prior double into of million, EPS translated line performance of flow the and superior free $XX and up we
year-to-date acquisition fiscal at cash anticipate disciplined performance free Even capital back leverage our finished capital with strong year-end, X, on at allocation enabling strategy. we further Our X.Xx optionality. flow net the continues our QX and being below future quarter and to solid allocation enable the and of Akorn July Xx
and update impact around various macro have a from for an consumer all Page changes to other turn of evolving and rapidly consumer year, pandemic Let's we pandemic. COVID-XX the resulting X environment other witnessed habits consumer the the habits as Since continued businesses. effects to evolving last
new and to diverse successfully. of a succeed we continued business, from many attributes: dynamic trends QX us began being themes, QX, our Fortunately, a having brands, manage major chain In leading agile supply some and to experienced enables under them organization experience for environment. our we each of positioned These this to are and numerous an fall X few in trends. well
as as QX began as cold well, head cough experienced Dramamine extended by First, the impacted in of higher certain categories trends into a business. consumer In continuation and including the rebound in uptick additional lice. that We to in travel previously COVID-XX well illnesses QX, our benefited around normalize. rebound habits sharp continue modest a categories
from benefiting Dramamine, brands Chloraseptic, these Nix of this rebound double each up in include which categories, Hydralyte consumption leading with Our are Luden's, digits. and
consumer rates leading therefore, as and consumers With of and boost. mind for in from retailers higher they our shifted have are we supply further poised shop, anticipation fueled consumers their market order demand this positions, of purchasing media. Both in to near-term Second, broadly our the top performance. QX concerns our trends benefit being noted and
For ours. concerns supply share. strong the want ordering to increased as vaccine example, and be have to retailers channel, risks support this and as do such generated drove leading distribution trends foot in higher increased drug at broad traffic shelf the in of consumption also we potential channel a broad market not without brands where takeaway This
costs certain we and are supply to evaluating elevated others, the navigate margin important gross well are impacts. impact similar later, global will review it's note, and chain to in positioned the constraints, we any occurring to Third, watching but Chris marketplace.
Our savings brand cost ongoing asset-light quickly portfolio give the react actions to the and manufacturing us efforts marketplace and ability leading in challenges as necessary. to through both strategy price
our Now a for brand-building let's strategy. turn Slide on to midyear update X
portfolio for outpaced growth. brand fiscal our share has market category year-to-date, For our
Clear many recovery expand position to On of a are continues the Pocket brand-building In fiscal success the Clear to in Eyes brand months but efforts the relief. we discussed, its leading Gaviscon side with channel to success year-to-date forward remains just in page growth on X Clear This we've with the Eyes I in in quarters. convenience strong continue innovation utilizing TheraTears consumers helped to travel in redness consumer particularly 'XX. work right and the is of where rebound the performance a first leader page Canada category performance as of our had by brand strong for we side full the driven W our look spectrum growth marketing, deliver X long-term is our the for categories of a strategies left the experience seek that superior product. GI, of the in same Eyes And Care, in also treatment. both experience Pal market-leading and long-term experience. We market by these supported Fleet. solid coming shown to continue Eye by In Compound brand for in executing continue Skin, share
performance of share categories year-to-date and the result with growing brands our our of proud are share. a long-term market positioning This portfolio majority strategy. vast our is largest and to testament We
ago our let's double e-commerce. that continued our update across e-commerce consumer our over today When digits for we turn leader is a year comparison. by health driven an success we to in Now retail our care, grow Slide partners. and continue Impressively, our despite in e-commerce fiscal on our channel to a which investments business, as began in This to sales. early in e-commerce this year, prior doubled the sales X acceleration overnight online all saw XX% of of rapid effectively enables
digital content consumers. the online timely of to continue consumers the We share e-commerce Shown win few targeted and right page through advertising. of our examples. engaging, investments with use We across on are messaging our the a with end with in and expanding goal
the For Meanwhile, connections product campaigns Compound for treatment finder brands, online behind W, as them. consumers and such DenTek other its right engaging consumers. with skin help deepen content solution find web help
X continue around oral efforts as are daily DenTek in care for of their a and reminder part engage to offerings the a further care many assortment These the we broad oral examples us enthusiasts, of that are online routine. used our e-commerce campaigns the growth. position of For
to through Chris to the over it turn walk financials. I'll Now